22 May 2013
Keywords: fda, oks, tercica, increlex, primary, igfd, california
Article | 05 September 2005
California, USA-based drugmaker Tercica says that the Food and Drug Administration has approved its drug candidate Increlex (mecasermin,
rDNA origin) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 September 2005
© 2013 thepharmaletter.com